Practice Uncertainties Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer? BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k1202 (Published 03 May 2018) Cite this as: BMJ 2018;361:k1202 Article Related content Metrics Responses Peer review Data supplement Web Extra: Data Supplement - ${data-supp-description} Related articles Practice Lower urinary tract symptoms in an older man Published: 18 April 2017; BMJ 357 doi:10.1136/bmj.j1493 Analysis Renaming low risk conditions labelled as cancer Published: 12 August 2018; BMJ 362 doi:10.1136/bmj.k3322 Practice Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline Published: 05 September 2018; BMJ 362 doi:10.1136/bmj.k3581 See more NICE recommends MRI for suspected prostate cancer to reduce biopsies BMJ December 13, 2018, 363 k5290; DOI: https://doi.org/10.1136/bmj.k5290 Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline BMJ September 05, 2018, 362 k3581; DOI: https://doi.org/10.1136/bmj.k3581 Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis BMJ September 05, 2018, 362 k3519; DOI: https://doi.org/10.1136/bmj.k3519 Sixty seconds on . . . prostate cancer BMJ March 27, 2018, 360 k1385; DOI: https://doi.org/10.1136/bmj.k1385 PSA screening significantly cuts risk of death from prostate cancer, review finds BMJ September 05, 2017, 358 j4120; DOI: https://doi.org/10.1136/bmj.j4120 Cited by... The elusive diagnosis of cancer: testing timesFulltext PDF Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guidelineFulltext PDF Renaming low risk conditions labelled as cancerFulltext PDF
